Substrate
Topic

glp-1

1 stories related to this topic, newest first.

Medicare to Cover Wegovy and Zepbound for Obesity Treatment at $50 Monthly Copay Starting July 1cnbc.com
health4 hrs ago

Medicare to Cover Wegovy and Zepbound for Obesity Treatment at $50 Monthly Copay Starting July 1

The temporary GLP-1 Bridge program will run through December 2027. Taxpayers will cover most costs for millions of new patients.

Stat
1 source